期刊文献+

酰肼介导的抗体定向偶联策略提高免疫层析试纸条检测性能

Hydrazide-Assisted Directional Antibody Conjugation of Gold Nanoparticles to Enhance the Performance of Immunochromatographic Assay
下载PDF
导出
摘要 以酰肼功能团修饰的胶体金作为试纸条的标记材料,利用酰肼基团可特异性地与抗体Fc片段醛基发生亲核加成反应的特性,实现抗体在胶体金纳米粒子(gold nanoparticles,AuNPs)表面的定向偶联。对比于碳二亚胺介导的共价偶联法,酰肼功能团介导的定向偶联需要更少的抗体标记量,更短的偶联时间,酰肼化胶体金免疫层析试纸条(hydrazided gold nanoparticles-based immunochromatographic assay,hAuNPs-ICA)检测玉米赤霉烯酮(zearalenone,ZEN)展示出更好的检测灵敏度;将hAuNPs-ICA检测ZEN加标的玉米样品,结果显示加标回收率介于83.1%~118.0%,批内、批间变异系数为3.9%~13.1%,表明hAuNPs-ICA具有较好的精密度和准确性。 Anti-zearalenone monoclonal antibodies(mAbs) were directionally conjugated on the surface of hydrazide group-functionalized gold nanoparticles because of the nucleophilic addition reaction between the aldehyde groups of the antibody Fc region and the hydrazide groups on gold nanoparticles(AuNPs). Compared with the carbodiimide-mediated covalent coupling method, the proposed directional coupling strategy showed several advantages such as use of less amounts of labeled antibody and shorter reaction time. The hydrazided gold nanoparticles-based immunochromatographic assay(hAuNPs-ICA) showed higher sensitivity for ZEN detection. Additionally, when hAuNPs-ICA was used to analyze ZENspiked maize samples, the average recoveries ranged from 83.1% to 118.0% with intra-and inter-batch coefficients of variation ranging from 3.9% to 13.1%, indicating good accuracy and precision.
作者 周梦君 周舒 黄小林 李响敏 熊勇华 ZHOU Mengjun;ZHOU Shu;HUANG Xiaolin;LI Xiangmin;XIONG Yonghua(State Key Laboratory of Food Science and Technology,Nanchang University,Nanchang 330047,China;College of Food Science and Technology,Nanchang University,Nanchang 330031,China)
出处 《食品科学》 EI CAS CSCD 北大核心 2022年第20期44-52,共9页 Food Science
基金 “十三五”国家重点研发计划重点专项(2018YFC1602202 2018YFC1602203 2018YFC1602505) 国家自然科学基金地区科学基金项目(31760485) 国家自然科学基金青年科学基金项目(31901780)。
关键词 免疫检测探针 酰肼 定向偶联 胶体金纳米粒子 玉米赤霉烯酮 immunoprobe hydrazide directional coupling colloidal gold nanoparticles zearalenone
  • 相关文献

参考文献1

二级参考文献49

  • 1Hamoudeh, M., Kamleh, M.A., Diab, R. and Fessi, H., Adv. Drug Deliv. Rev., 2008, 60:1329.
  • 2Janib, S.M., Moses, A.S. and MacKay, J.A., Adv. Drug Deliv. Rev., 2010, 62:1052.
  • 3Kim, J.H., Park, K., Nam, H.Y., Lee, S., Kim, K. and Kwon, I.C., Prog. Polym. Sci., 2007, 32:1031.
  • 4Srinivas, M., Aamtzen, E.H.J.G., Bulte, J.W.M., Oyen, W.J., Heerschap, A., de Vries, I.J.M. and Figdor, C.G., Adv. Drug Deliv. Rev., 2010, 62:1080.
  • 5Boschi, A., Uccelli, L., Duatti, A., Bolzati, C., Refosco, F., Tisato, F., Romagnoli, R., Baraldi, P.G., Varani, K. and Borea, P.A., Bioconjugate Chem., 2003, 14:1279.
  • 6Kim, C., Favazza, C. and Wang, L.V., Chem. Rev., 2010, 110:2756.
  • 7Schottelius, M., Wester, H.J., Reubi, J.C., Senekowitsch-Schmidtke, R. and Schwaiger, M., Bioconjugate Chem., 2002, 13:1021.
  • 8Schweitzer, D., Shearer, J., Rittenberg, D.K., Shoner, S.C., Ellison, J.J., Loloee, R., Lovell, S., Bamhart, D. and Kovacs, J.A., Inorg. Chem., 2002, 41:3128.
  • 9Walther, M., Jung, C.M., Bergmann, R., Pietzsch, J., Rode, K., Fahmy, K., Mirtschink, P., Stehr, S., Heintz, A., Wunderlich, G., Kraus, W., Pietzsch, H.J., Kropp, J., Deussen, A. and Spies, H., Bioconjugate Chem., 2006, 18:216.
  • 10Schroeder, A., Heller, D.A., Winslow, M.M., Dahlman, J.E., Pratt, G.W., Langer, R., Jacks, T. and Anderson, D.G., Nat Rev. Cancer, 2012, 12:39.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部